Integer (NYSE:ITGR – Get Free Report) issued its quarterly earnings results on Monday. The medical equipment provider reported $1.60 earnings per share for the quarter, topping analysts’ consensus estimates of $1.38 by $0.22, FiscalAI reports. The firm had revenue of $464.11 million during the quarter, compared to analysts’ expectations of $450.67 million. Integer had a net margin of 7.64% and a return on equity of 12.83%. Integer’s quarterly revenue was down 2.6% compared to the same quarter last year. During the same quarter in the prior year, the business earned $1.55 EPS.
Integer Stock Up 2.7%
Shares of NYSE:ITGR opened at $124.44 on Tuesday. The company has a market cap of $4.23 billion, a price-to-earnings ratio of 31.03, a PEG ratio of 2.89 and a beta of 0.61. The firm’s 50-day simple moving average is $94.58 and its 200-day simple moving average is $89.28. The company has a quick ratio of 2.38, a current ratio of 3.75 and a debt-to-equity ratio of 0.77. Integer has a fifty-two week low of $62.00 and a fifty-two week high of $125.54.
Key Stories Impacting Integer
Here are the key news stories impacting Integer this week:
- Positive Sentiment: KKR acquisition provides a clear valuation catalyst. KKR agreed to acquire Integer in an all-cash transaction valued at approximately $5.7 billion. Stockholders will receive $127 per share, a 28.8% premium to Integer’s 30-day volume-weighted average price and approximately a 51.8% premium to the price before the company began its strategic review. The deal is expected to close by year-end, subject to shareholder and regulatory approval. Integer to Be Acquired by KKR
- Positive Sentiment: Second-quarter earnings and revenue exceeded expectations. Integer reported adjusted earnings of $1.60 per share versus the $1.38 analyst consensus, while revenue of $464.1 million topped the $450.7 million estimate. EPS also improved from $1.55 in the year-ago quarter, supporting the view that operating performance remains resilient despite revenue declining 2.6% year over year. Integer Second Quarter 2026 Results
- Neutral Sentiment: Analyst downgrade reflects limited deal-related upside. Truist Financial downgraded Integer from “strong buy” to “hold.” With shares trading close to the $127 offer price, the downgrade likely reflects reduced upside potential rather than a deterioration in the company’s quarterly results.
- Negative Sentiment: Shareholder-law-firm investigations add execution risk. Several law firms are investigating whether Integer’s sale to KKR provides a fair price or involved potential breaches of fiduciary duty. These announcements do not necessarily indicate wrongdoing, but litigation or demands for a higher offer could delay or complicate the transaction. Shareholder Investigation
- Negative Sentiment: Integer withdrew its financial outlook and canceled its earnings call because of the pending acquisition. This reduces visibility into standalone performance and leaves investors focused primarily on deal completion, including regulatory and shareholder approvals. Integer will become privately held if the transaction closes.
Institutional Inflows and Outflows
Analysts Set New Price Targets
Several equities research analysts have recently weighed in on the stock. Raymond James Financial downgraded shares of Integer from a “moderate buy” rating to a “hold” rating in a research note on Monday. Citigroup boosted their price target on Integer from $92.00 to $96.00 and gave the company a “neutral” rating in a research report on Wednesday, July 8th. Piper Sandler downgraded Integer from an “overweight” rating to a “hold” rating and set a $127.00 price objective for the company. in a research note on Monday. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Integer in a research report on Thursday, June 18th. Finally, Zacks Research upgraded Integer from a “strong sell” rating to a “hold” rating in a research note on Monday, July 20th. One investment analyst has rated the stock with a Strong Buy rating, one has issued a Buy rating and twelve have issued a Hold rating to the company. According to MarketBeat, the stock currently has a consensus rating of “Hold” and a consensus target price of $103.71.
Read Our Latest Stock Analysis on ITGR
About Integer
Integer Holdings Corporation (NYSE: ITGR) is a global provider of outsourced medical device design, development and manufacturing solutions. The company partners with leading medical technology firms to deliver complex components, subsystems and finished devices across a range of therapeutic areas. Its services encompass concept and product design, precision machining, microelectronic assembly, terminal sterilization and regulatory support, enabling customers to accelerate time to market and optimize product performance.
Integer’s product portfolio is organized into two core segments: Advanced Delivery and MedTech.
Read More
- Five stocks we like better than Integer
- Tyson Foods Offers a Meaty Opportunity for Income Investors
- SpaceX’s First Earnings Report Could Decide Whether Shorts or Bulls Have Control
- Why Rare Earth Processing Could Be the Real 2027 Opportunity
- The S&P 493 Are Staging a Comeback—This Value ETF Offers Broad Exposure
Receive News & Ratings for Integer Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Integer and related companies with MarketBeat.com's FREE daily email newsletter.
